Personalized immunotherapy against several neuronal and brain tumors
US-11529400-B1 · Dec 20, 2022 · US
This page is not indexed by search engines while we improve data quality.
Immatics Biotechnologies Gmbh patents in 2022
Immatics Biotechnologies Gmbh was listed as an assignee on 204 patent publications in 2022.
| Metric | Value |
|---|---|
| Company | Immatics Biotechnologies Gmbh |
| Year | 2022 |
| Patents | 204 |
Patents
Representative publications for Immatics Biotechnologies Gmbh in 2022.
Personalized immunotherapy against several neuronal and brain tumors
US-11529401-B2 · Dec 20, 2022 · US
Personalized immunotherapy against several neuronal and brain tumors
US-11524059-B2 · Dec 13, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers
US-2022389068-A1 · Dec 8, 2022 · US
Peptides and t cells for use in immunotherapeutic treatment of various cancers
US-2022387566-A1 · Dec 8, 2022 · US
Top CPC classifications
Most common classification codes for Immatics Biotechnologies Gmbh in 2022.
| CPC | Patents |
|---|---|
| A61P35/00 | 200 |
| A61K40/11 | 195 |
| A61K39/0011 | 191 |
| C07K14/7051 | 188 |
| C12N5/0636 | 178 |
Related pages
Navigate to parent entity pages.